Eosinophilic granulomatosis with polyangiitis: sequential use of mepolizumab following rituximab for inadequate asthma control despite vasculitis remission. Reumatismo, [S. l.], v. 75, n. 4, 2023. DOI: 10.4081/reumatismo.2023.1588. Disponível em: https://www.reumatismo.org/reuma/article/view/1588. Acesso em: 26 apr. 2025.